3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
2394
Neoplasms
1813
Carcinoma, Non-Small-Cell Lung
1596
Prostatic Neoplasms
1296
Colorectal Neoplasms
1138
Lung Neoplasms
981
Neoplasm Metastasis
830
Multiple Myeloma
791
Leukemia, Myeloid, Acute
767
Ovarian Neoplasms
674
Pancreatic Neoplasms
661
Melanoma
659
Squamous Cell Carcinoma of Head and Neck
584
Carcinoma, Hepatocellular
566
Recurrence
562
Brain Neoplasms
526
Glioblastoma
512
Head and Neck Neoplasms
500
Stomach Neoplasms
497
Triple Negative Breast Neoplasms
464
Lymphoma
453
Uterine Cervical Neoplasms
449
Carcinoma, Renal Cell
423
Precursor Cell Lymphoblastic Leukemia-Lymphoma
410
Lymphoma, Non-Hodgkin
388
Endometrial Neoplasms
381
Sarcoma
368
Lymphoma, Follicular
356
Urinary Bladder Neoplasms
354
Hematologic Neoplasms
351
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Immune Reconstitution Inflammatory Syndrome
×
1 year
×
Clear all
NCT01916057
2025-09-08
CANHPARI
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
100 enrolled